Gartner Research

Radio Frequency ID Technology Helps Secure the Biopharma Supply Chain by Reducing Drug Counterfeiting

Published: 28 April 2006

ID: G00139393

Analyst(s): Carol Rozwell


Biopharmas evaluating RFID to secure a vulnerable supply chain should examine the lessons learned by early adopters so they can understand the opportunities, challenges and organizational commitment required for success.

Table Of Contents
  • Overview
  • Predictions
  • Concern Over Counterfeit Drugs Is Increasing
  • Biopharma A's RFID Experience: An Example of Track and Trace
  • Biopharma B's Use of RFID: An Example of Authentication
  • The Current Status of RFID Technology
  • Recommendations

©2020 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.